Information  X 
Enter a valid email address

Jarvis Securities (JIM)

  Print      Mail a friend

Tuesday 07 May, 2019

Jarvis Securities

Dividend Declaration

RNS Number : 2361Y
Jarvis Securities plc
07 May 2019
 

Jarvis Securities plc

 

("Jarvis" or "the Company")

 

DIVIDEND DECLARATION

 

The Board of Jarvis announces that it is declaring a second quarterly interim dividend of 6.5 pence per share, to be paid on 6 June 2019 to shareholders on the register on 17 May 2019 and the shares will become ex-dividend on 16 May 2019.

 

DIVIDEND REINVESTMENT PLAN

 

A Dividend Reinvestment Plan is being offered and the final date for elections for reinvestment of the second quarterly interim dividend is 23 May 2019. Any shareholder requiring further information should contact the Company.

 

Enquiries:

 

Jarvis Securities plc 01892 510 515

 

Andrew Grant

 

Jolyon Head

 

WH Ireland Limited 0113 3946600

 

Katy Mitchell / Chris Savidge

 

Notes:

 

Jarvis Securities plc is the holding company for Jarvis Investment Management Limited (AIM: JIM.L) a stock broking company and outsourced service provider for bespoke tailored financial administration. Jarvis was established in 1984 and is a member of the London Stock Exchange; a broker dealer member of ISDX Markets, authorised and regulated by the Financial Conduct Authority and an HM Revenue & Customs approved ISA manager. As well as normal retail broking Jarvis provides cost effective and flexible share trading facilities within ISA and SIPP wrappers.

 

Jarvis provides outsourced and partnered financial administration services to a number of third party organisations. These organisations include advisers, stockbrokers, banks and fund managers. Jarvis can tailor its administration processes to the requirements of each organisation and has a strong reputation for flexibility and cost-effectiveness.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DIVFMGGKGNKGLZM

a d v e r t i s e m e n t